Screener
Kymera Therapeutics KYMR Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $9.43B.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's market capitalization?
- Kymera Therapeutics (KYMR) reported market capitalization of $9.43B in Q2 2026.
- How has Kymera Therapeutics's market capitalization changed year-over-year?
- Kymera Therapeutics's market capitalization increased by 207.3% year-over-year, from $3.07B to $9.43B.
- What is the long-term trend for Kymera Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Kymera Therapeutics's market capitalization has grown at a 17.6% compound annual growth rate (CAGR), from $2.77B to $6.22B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Kymera Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude